Drug Shortage Report for SANDOZ ESOMEPRAZOLE
| Report ID | 125150 |
| Drug Identification Number | 02460920 |
| Brand name | SANDOZ ESOMEPRAZOLE |
| Common or Proper name | SANDOZ ESOMEPRAZOLE |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | ESOMEPRAZOLE |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100GRT BO CA |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-09-25 |
| Estimated end date | 2020-12-25 |
| Actual end date | 2021-01-12 |
| Shortage status | Resolved |
| Updated date | 2021-01-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2021-01-13 | English | Compare |
| v6 | 2021-01-12 | French | Compare |
| v5 | 2021-01-12 | English | Compare |
| v4 | 2020-12-14 | French | Compare |
| v3 | 2020-12-14 | English | Compare |
| v2 | 2020-09-28 | French | Compare |
| v1 | 2020-09-28 | English | Compare |
Showing 1 to 7 of 7